Type 2 diabetes mellitus only | Type 2 diabetes mellitus with severe mental illness | ||||
n | % | n | % | ||
Total | 54 498 | 2272 | |||
Age (years), mean (SD)* | 63 | 14 | 60 | 13 | F=110.29, p<0.001 |
Gender | |||||
Female | 24 916 | 46 | 1146 | 50 | Pearson’s χ2=19.58, p<0.001 |
Male | 29 582 | 54 | 1126 | 50 | |
Ethnicity | |||||
White British | 12 363 | 23 | 578 | 25 | Pearson’s χ2=184.08, p<0.001 |
Irish | 399 | 1 | 24 | 1 | |
Black African | 7440 | 14 | 326 | 14 | |
Black Caribbean | 6710 | 12 | 455 | 20 | |
Bangladeshi | 16 105 | 30 | 569 | 25 | |
Indian | 6697 | 12 | 189 | 8 | |
Pakistani | 4319 | 8 | 110 | 5 | |
Chinese | 465 | 1 | 21 | 1 | |
Townsend deprivation score | |||||
Least deprived, Q1 | 11 597 | 21 | 306 | 13 | Pearson’s χ2=88.57, p<0.001 |
Q2 | 11 690 | 21 | 481 | 21 | |
Q3 | 10 616 | 19 | 500 | 22 | |
Q4 | 10 595 | 19 | 501 | 22 | |
Most deprived, Q5 | 10 000 | 18 | 484 | 21 | |
Exception-reported† | |||||
Never | 54 457 | 100 | 1958 | 86 | Pearson’s χ2=6631.11, p<0.001 |
At least once | 41 | 0 | 314 | 14 | |
Antidiabetes medications | |||||
Diet controlled | 7084 | 13 | 269 | 12 | Pearson’s χ2=15.84, p<0.001 |
Oral/non-insulin injectable | 38 529 | 71 | 1563 | 69 | |
Insulin | 8885 | 16 | 440 | 19 | |
Prescribed antipsychotics | |||||
None | 53 245 | 98 | 608 | 27 | Pearson’s χ2=2.25, p<0.001 |
Any | 1253 | 2 | 1664 | 73 | |
Total consultations over the study period, mean (SD) | 8.9 | 18.7 | 14.5 | 27.1 | F=186.59, p<0.001 |
Number of HbA1c assessments over the study period, mean (SD) | 9.9 | 7.1 | 10.6 | 7.4 | F=18.36, p<0.001 |
*On date of extraction (January 2018).
†From mental health QOF indicators.
HbA1c, glycated hemoglobin; Q, quintile; QOF, Quality and Outcomes Framework.